Western IRB, a provider of ethical research review serving 2,300 academic medical centers and hospitals, announced today an alliance with Huron, a global professional services firm serving the health care, higher education, life sciences, and commercial sectors.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
